In May 2013 the authoritative publication „Forbes” interviewed the founder of the company „Nervostrong Medica”. „Forbes” praised the fact that in a relatively short time - three years - a pharmaceutical company was created, which with only three products reached a turnover exceeding € 1,000,000, but the main pharmaceutical market players over the past five years have gained the opportunity to earn an additional more than € 5,000,000. Furthermore, this result was achieved in the relatively small Latvian pharmaceutical market.